Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Mexico for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Mexico only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Mexico (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Edward Lewiecki (NPI 1861441735)

Field	Value
Entity Type	Individual
Organization	Edward Lewiecki
Address	300 Oak St Ne
City	Albuquerque
State	NM
ZIP	87106
Taxonomy	Internal Medicine Physician
NPI Enumerated	May 9, 2006

Payer Source	Total Paid
Medicare	$1.8M
Medicaid	$0

Key Findings

This provider’s Medicare business is the sole payer footprint on file: total Medicare revenue is $1.8M while there is no Medicaid billing on file, making the practice effectively single‑payer Medicare in scale. That payer concentration should shape any assessment of market exposure and contracting leverage.

Revenue is highly concentrated in a very small set of services: the precomputed top 3 Medicare codes account for 92.2% of this provider’s total Medicare revenue. That concentration indicates a narrow revenue base driven by a few high‑revenue therapies rather than a broadly diversified mix of office and procedure revenue.

J0897 is the single largest revenue driver for this provider: 54.5K claims, $18 avg paid/claim, $980.6K revenue (53.8% of this provider's total Medicare revenue) and it ranks #17 of 10057 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code). This makes the provider an exceptional national outlier for denosumab administration and indicates operational focus and scale in that specific injectable therapy.

J3111 is the second major revenue source with 80K claims, $8 avg paid/claim, $639.7K revenue (35.1% of this provider's total Medicare revenue) and ranks #25 of 970 providers nationally (98th percentile; notably above typical national volume for this code). High romosozumab volume alongside J0897 reinforces a business profile centered on osteoporosis biologic therapies delivered in the office or infusion setting.

The provider also shows a high relative volume of bone‑health imaging and ongoing outpatient management: 77080 appears with 775 claims and $27.1K revenue (1.5%) and ranks #497 of 17308 providers nationally (97th percentile), while 77089 has 462 claims and $11.6K revenue (0.6%) and ranks #22 of 348 providers nationally (94th percentile). These DXA and trabecular bone score services, paired with E/M volume (99214: 748 claims, $61.3K revenue (3.4%), rank #22761 of 479517 (95th percentile); 99213: 616 claims, $35.1K revenue (1.9%), rank #18503 of 457151 (96th percentile)), point to integrated osteoporosis management—diagnosis, monitoring, and in‑office treatment.

Several utilization metrics mark the provider as a competitive outlier on a national scale for injection and infusion administration: 96372 shows 1.3K claims, $12.9K revenue (0.7%) and ranks #219 of 58224 providers nationally (100th percentile; extreme outlier), and 99205 shows 159 claims, $21.9K revenue (1.2%) and ranks #799 of 66257 providers nationally (99th percentile; extreme outlier). Collectively these ranks indicate a practice with unusually high throughput for in‑office procedures and higher‑complexity new patient visits relative to national peers.

The business model implied by the code mix—dominant revenue from J0897 and J3111 plus onsite DXA and frequent injections—creates operational advantages (scale in biologic administration) but also a concentration risk: with the top 3 codes accounting for 92.2% of Medicare revenue, changes in utilization patterns, clinical guidelines, or reimbursement for these specific drugs and administration codes could materially affect revenue. Analysts should treat future reimbursement policy shifts for osteoporosis biologics as a primary financial sensitivity for this provider.

The provider’s NPI tenure (enumerated 2006-05-09, ~20 years ago) indicates an established practice likely with sustained referral sources and operational continuity. Combined with the specialized, high‑volume service mix documented above, tenure supports the view of a mature, niche outpatient practice focused on bone health and biologic injection services rather than a general primary‑care panel with mixed payer exposure.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

19 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0897	Injection, denosumab, 1 mg	54,480	$20	$980.6K
J3111	Injection, romosozumab-aqqg, 1 mg	79,970	$10	$639.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	750	$80	$61.3K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	620	$60	$35.1K
77080	The provider performs an imaging procedure, called dual–energy X–ray absorptiometry (DXA), of one or more bony areas on the trunk to determine the bone mineral density (BMD) and whether the patient…	780	$40	$27.1K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	160	$140	$21.9K
99212	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,…	360	$40	$13.9K
96372	A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician…	1,290	$10	$12.9K
77089	The provider uses imaging data and software to calculate a patient’s trabecular bone score. The service includes an interpretation and report on the patient’s fracture risk.	460	$30	$11.6K
99443	N/A	90	$80	$7.2K

Showing 1–10 of 19

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 19 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Mexico Distribution

Edward Lewiecki — 7 of 19 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Mexico

Full comparison — all codes billed, vs. state median

19 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3111	1	10	30,030	$10	$299.1K
J0897	1	50	3,150	$20	$113.2K
99214	80	2,700	90	$70	$12.9K
99215	889	960	40	$110	$7.8K
99213	83	2,440	60	$50	$7.3K
96365	21	40	80	$40	$6K
77089	3	10	160	$20	$5.6K
77080	4	70	120	$20	$5K
99443	10	80	30	$80	$4.7K
99205	4	340	20	$140	$4.3K

Showing 1–10 of 19

Related Providers

Other providers that share a Tax Identification Number (TIN) with Edward Lewiecki, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Lance Rudolph	NM	Internal Medicine Physician	$1.3M	$0

Nearby Providers

Other providers in the same ZIP code as Edward Lewiecki, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Unm Hospital	NM	General Acute Care Hospital	$0	$462.9M
Presbyterian Healthcare Services	NM	General Acute Care Hospital	$0	$345.3M
Unm Medical Group Inc	NM	Multi-Specialty Clinic/Center	$0	$113.5M
Dungarvin New Mexico LLC	NM	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$84.6M
Perinatal Associates Of New Mexico, Ltd	NM	Maternal & Fetal Medicine Physician	$0	$62.6M
Optumcare New Mexico LLC	NM	Family Medicine Physician	$0	$23.6M
Unm Hospital	NM	Psychiatric Hospital Unit	$228.5K	$17.6M
Family Eye Care/children's Eye Center Of New Mexico, P.C.	NM	Ophthalmology Physician	$0	$13.3M
Pediatrix Medical Group Of New Mexico, P.C.	NM	Neonatal-Perinatal Medicine Physician	$0	$11.9M
Guardian Flight LLC	NM	Air Ambulance	$372.6K	$6.9M

Edward Lewiecki — Billing Profile & Reimbursement Data

Sign up for Edward Lewiecki — Billing Profile & Reimbursement Data policy alerts

Edward Lewiecki — Billing Profile & Reimbursement Data

Sign up for Edward Lewiecki — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References